Disease Intelligence
As part of its Infectious Disease Analytics (IDA) solution, Airfinity offers more comprehensive analysis of disease burden and its interaction with market indicators via bi-annual disease-specific intelligence reports and briefings, as well as email alerts.
Along with high-level summaries of answers to key questions in the area, you can expect detailed analysis across:
Disease Burden: Global, regional and country-level disease burden forecasts and estimates of true incidence, including demographic breakdowns.
Pipeline: Overview of the development landscape, assessments of candidates in the pipeline, estimated approval dates, and latest efficacy results.
Commercial: Projected market segmentation and funding landscape, growth and size, including forecasted demand scenarios.
Fill out the form and tell us which disease areas you’re interested in. A member of the team will be in touch with more information about how to subscribe and access the reports.
Get In Touch!
We’ll need a few short details about you and your business.
Get In Touch!
We’ll need a few short details about you and your business.
What our users say?
“Airfinity has again and again shown they can provide very accurate and actionable predictions for disease trajectories. That’s why their analytics became an essential tool for me and the White House when leading outbreak responses such as COVID-19, mpox, Marburg Virus Disease and Avian Flu.”
Nikki Romanik, Former Special Assistant to the President, Deputy Director and Chief of Staff,
Office of Pandemic Preparedness and Response Policy, White House
In a dynamic environment, Airfinity enabled us to remain on track with daily developments to enable more accurate decision-making. Airfinity combines nimbleness of real time data and their group of scientists that can analyse, model and provide strategic analysis for critical decision making.”
Iskra Reic, Executive Vice-President
Astrazeneca
“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”
Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister
“Airfinity has been instrumental in our country's COVID response.”
Head of UK Government
Vaccine Task Force
“Probably the most expansive, accurate and helpful of the multiple data sets on an international scale”
Sir John Bell ,
University of Oxford